|
AGGF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.632190E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.472000E-02 |
| Normal-vs-Stage2 |
1.883640E-01 |
| Normal-vs-Stage3 |
3.88340000000431E-05 |
| Normal-vs-Stage4 |
9.11420000027086E-07 |
| Stage1-vs-Stage2 |
7.443200E-01 |
| Stage1-vs-Stage3 |
3.379300E-03 |
| Stage1-vs-Stage4 |
7.154600E-04 |
| Stage2-vs-Stage3 |
2.428200E-01 |
| Stage2-vs-Stage4 |
1.244000E-01 |
| Stage3-vs-Stage4 |
5.601800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.390500E-04 |
| Normal-vs-AfricanAmerican |
1.574540E-04 |
| Normal-vs-Asian |
1.227220E-01 |
| Caucasian-vs-AfricanAmerican |
1.367760E-01 |
| Caucasian-vs-Asian |
8.639000E-01 |
| AfricanAmerican-vs-Asian |
7.100200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.370300E-04 |
| Normal-vs-Female |
2.420000E-03 |
| Male-vs-Female |
6.373800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.835400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.842550E-03 |
| Normal-vs-Age(61-80Yrs) |
1.820520E-03 |
| Normal-vs-Age(81-100Yrs) |
8.596300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.092000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.612380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.064600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.050000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.920600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.377800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.507000E-01 |
| Normal-vs-Grade 2 |
2.155800E-01 |
| Normal-vs-Grade 3 |
1.6864999999977E-05 |
| Normal-vs-Grade 4 |
6.78879996662829E-09 |
| Grade 1-vs-Grade 2 |
9.656800E-01 |
| Grade 1-vs-Grade 3 |
2.096800E-01 |
| Grade 1-vs-Grade 4 |
1.054250E-02 |
| Grade 2-vs-Grade 3 |
1.724860E-03 |
| Grade 2-vs-Grade 4 |
7.76559999970949E-07 |
| Grade 3-vs-Grade 4 |
1.600490E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.881400E-01 |
| Normal-vs-ccB subtype |
2.03669999999656E-05 |
| ccA subtype-vs-ccB subtype |
2.152200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.578600E-03 |
| Normal-vs-N1 |
4.560300E-02 |
| N0-vs-N1 |
4.496000E-01 |
|
|
